case_images: PMC5056304_01
case_images: IgD levels over the course of 6 years of treatment.
case_images: CRIONM2016-2490168.001.jpg
case_images: PMC5056304_01_CRIONM2016-2490168.001.jpg
case_images: fig1
case_images: December 2015 were 4000 mg/L and came down drastically to 5 mg/L in May 2016 after 5 cycles of daratumumab showing very good partial response (Figure 1). During his first infusion, he developed a grade 3 infusion reaction.
case_images: Transfusion requirements prior to starting daratumumab and after daratumumab.
case_images: CRIONM2016-2490168.002.jpg
case_images: PMC5056304_01_CRIONM2016-2490168.002.jpg
case_images: fig2
case_images: His transfusion requirements which had been very high throughout his disease course requiring multiple transfusions with packed red blood cells (PRBCs) also came down dramatically with stable hemoglobin levels after the start of daratumumab (Figure 2).